ATE364629T1 - Methoden zur herstellung von op-1 morphogen analoge - Google Patents

Methoden zur herstellung von op-1 morphogen analoge

Info

Publication number
ATE364629T1
ATE364629T1 AT97905604T AT97905604T ATE364629T1 AT E364629 T1 ATE364629 T1 AT E364629T1 AT 97905604 T AT97905604 T AT 97905604T AT 97905604 T AT97905604 T AT 97905604T AT E364629 T1 ATE364629 T1 AT E364629T1
Authority
AT
Austria
Prior art keywords
methods
morphogen
analogs
producing
morphogen analogs
Prior art date
Application number
AT97905604T
Other languages
German (de)
English (en)
Inventor
Peter Keck
Diana Griffith
William Carlson
David Rueger
Kuber Sampath
Original Assignee
Curis Inc
Univ Brandeis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curis Inc, Univ Brandeis filed Critical Curis Inc
Application granted granted Critical
Publication of ATE364629T1 publication Critical patent/ATE364629T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97905604T 1996-01-22 1997-01-22 Methoden zur herstellung von op-1 morphogen analoge ATE364629T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58955296A 1996-01-22 1996-01-22

Publications (1)

Publication Number Publication Date
ATE364629T1 true ATE364629T1 (de) 2007-07-15

Family

ID=24358486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905604T ATE364629T1 (de) 1996-01-22 1997-01-22 Methoden zur herstellung von op-1 morphogen analoge

Country Status (8)

Country Link
US (2) US6273598B1 (enExample)
EP (1) EP0876401B1 (enExample)
JP (1) JP2000501744A (enExample)
AT (1) ATE364629T1 (enExample)
AU (1) AU725295B2 (enExample)
CA (1) CA2244228A1 (enExample)
DE (1) DE69737809T2 (enExample)
WO (1) WO1997026277A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030185792A1 (en) * 1996-01-22 2003-10-02 Curis, Inc. Morphogen analogs of bone morphogenic proteins
US20040006011A1 (en) * 1996-07-12 2004-01-08 Gour Barbara J. Peptidomimetic modulators of cell adhesion
US7122623B2 (en) 1996-07-12 2006-10-17 Adherex Technologies, Inc. Compounds and methods for modulating cell adhesion
US5922558A (en) * 1997-09-12 1999-07-13 Lumigen, Inc. Methods and compositions for generating chemiluminescence with a peroxidase
DE19831758A1 (de) * 1998-07-15 2000-02-03 Jerini Bio Tools Gmbh Ligandenbestimmung für Proteine
AU2001231154A1 (en) * 2000-01-24 2001-07-31 Adherex Technologies Inc. Peptidomimetic modulators of cell adhesion
US20040005309A1 (en) * 2002-05-29 2004-01-08 Symbiontics, Inc. Targeted therapeutic proteins
EP1974752B1 (en) 2001-04-30 2012-09-26 BioMarin Pharmaceutical Inc. Subcellular targeting of therapeutic proteins
US7629309B2 (en) * 2002-05-29 2009-12-08 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US7560424B2 (en) 2001-04-30 2009-07-14 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US20030072761A1 (en) * 2001-10-16 2003-04-17 Lebowitz Jonathan Methods and compositions for targeting proteins across the blood brain barrier
WO2003059291A2 (en) * 2002-01-10 2003-07-24 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
JP4654029B2 (ja) * 2002-06-17 2011-03-16 トラソス インコーポレイテッド 単一ドメインｔｄｆ関連化合物およびその類似体
AU2002950183A0 (en) * 2002-07-12 2002-09-12 The Council Of The Queensland Institute Of Medical Research Expression of hydrophobic proteins
US20040093164A1 (en) * 2002-11-08 2004-05-13 Carlson William D. Computer system and methods for producing morphogen analogs of human TDF-1
CA2517848A1 (en) * 2003-01-21 2004-08-05 The Trustees Of The University Of Pennsylvania Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel kcsa
US20040204862A1 (en) * 2003-04-11 2004-10-14 Wainer Irving W. Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
US20050009877A1 (en) * 2003-05-15 2005-01-13 Henry Lu Methods of identifying HCV NS5B polymerase inhibitors and their uses
CA2553955C (en) * 2004-02-10 2012-08-28 Zystor Therapeutics, Inc. Acid alpha-glucosidase and fragments thereof
WO2005097825A2 (en) * 2004-03-31 2005-10-20 Xencor, Inc. Bmp-7 variants with improved properties
CA2897218A1 (en) 2004-06-17 2006-01-26 Thrasos Innovation, Inc. Tdf-related compounds and analogs thereof
PT2497780E (pt) * 2005-09-20 2015-08-20 Thrasos Innovation Inc Compostos relacionados com tdf e seus análogos
AU2012201060B2 (en) * 2005-09-20 2015-01-22 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof
US7659250B2 (en) * 2005-12-22 2010-02-09 Centocor, Inc. BMP-7 variant compositions, methods and uses
JP5100662B2 (ja) * 2005-12-22 2012-12-19 セントカー・インコーポレーテツド Ｂｍｐ−７変異体組成物、方法および使用
CA2669347A1 (en) * 2006-11-13 2008-05-29 Zystor Therapeutics, Inc. Methods for treating pompe disease
AU2009214629A1 (en) * 2008-02-13 2009-08-20 Eric T. Choi BMP-7 for use in treating vascular sclerosis
US20090291967A1 (en) * 2008-03-05 2009-11-26 Adherex Technologies, Inc. Small molecule modulators of cell adhesion
ES2629853T3 (es) * 2008-05-07 2017-08-16 Biomarin Pharmaceutical Inc. Péptidos de dirección lisosómica y usos de los mismos
EP2475376B1 (en) 2009-06-17 2016-03-30 BioMarin Pharmaceutical Inc. Formulations for lysosomal enzymes
US9721070B2 (en) 2013-12-19 2017-08-01 Chevron Phillips Chemical Company Lp Selective oligomerization catalysts and methods of identifying same
CN109311957A (zh) * 2015-08-25 2019-02-05 伊斯迪德股份公司 诱导组织形成的化合物及其应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908773A (en) 1987-04-06 1990-03-13 Genex Corporation Computer designed stabilized proteins and method for producing same
US4881175A (en) 1986-09-02 1989-11-14 Genex Corporation Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
DE68929472T2 (de) * 1988-04-08 2004-05-13 Stryker Corp., Kalamazoo Biosynthetische knochenbildende Proteine, und sie enthaltende knochenbildende Vorrichtungen
US5284756A (en) * 1988-10-11 1994-02-08 Lynn Grinna Heterodimeric osteogenic factor
US5061786A (en) 1989-05-25 1991-10-29 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
US5118791A (en) 1989-05-25 1992-06-02 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
GB8914122D0 (en) * 1989-06-20 1989-08-09 Wellcome Found Polypeptide expression
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5688678A (en) * 1990-05-16 1997-11-18 Genetics Institute, Inc. DNA encoding and methods for producing BMP-8 proteins
WO1992001933A1 (en) 1990-07-20 1992-02-06 E.I. Du Pont De Nemours And Company Generation of a complete set of structural coordinates of a molecule from a set of partial coordinates
WO1992004914A1 (en) 1990-09-14 1992-04-02 The Trustees Of The University Of Pennsylvania Design of bioactive peptides based on immunoglobulin structure
JPH07500487A (ja) * 1990-10-18 1995-01-19 ストライカー コーポレイション 骨形成ペプチド
US5824647A (en) * 1990-12-12 1998-10-20 Postlethwaite; Arnold E. Chemotactic wound healing peptides
US5331573A (en) * 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
JPH06508623A (ja) * 1991-06-19 1994-09-29 エス・アール・アイ・インターナシヨナル 抗ウィルス剤としてのインフルエンザウィルスのｍ−蛋白質ペプチド
WO1993002209A1 (en) 1991-07-22 1993-02-04 The Regents Of The University Of California Methods of designing specific affectors using three-dimensional conformation of enzyme/affector complex
JPH05262788A (ja) 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US5353236A (en) 1992-04-23 1994-10-04 The Board Of Trustees Of The Leland Stanford University High-resolution crystallographic modelling of a macromolecule
US5322933A (en) 1992-05-07 1994-06-21 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Crystal structure of TGF-β-2
AU4801393A (en) * 1992-08-03 1994-03-03 New York University Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan
EP0690871A4 (en) * 1993-01-12 1999-10-20 Univ Johns Hopkins Med GROWTH DIFFERENTIATION FACTOR-5
US5581476A (en) * 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
EP0746569A4 (en) 1993-02-03 1999-03-24 Amrad Corp Ltd DETERMINANT FOR FIXING THE RECEPTOR FROM THE LEUKEMIA INHIBITION FACTOR
US5453937A (en) 1993-04-28 1995-09-26 Immunex Corporation Method and system for protein modeling
US5637480A (en) * 1993-05-12 1997-06-10 Genetics Institute, Inc. DNA molecules encoding bone morphogenetic protein-10
EP0788370A4 (en) 1993-07-09 1998-07-08 Smithkline Beecham Corp CYCLIC, PARTIAL RANDOM PEPTIDE LIBRARIES
GB9317120D0 (en) 1993-08-17 1993-09-29 Royal Postgrad Med School Human serum amyloid p component
US5856122A (en) 1993-08-24 1999-01-05 University Of Alberta Modification of pertussis toxin
US5652334A (en) 1993-09-08 1997-07-29 City Of Hope Method for design of substances that enhance memory and improve the quality of life
US5565352A (en) * 1993-11-24 1996-10-15 Arch Development Corporation Deubiquitinating enzyme: compositions and methods
JPH09505603A (ja) 1993-11-26 1997-06-03 ヘンドリー，ローレンス，ビー． レセプター−リガンド−ｄｎａ相互作用に係わる薬剤の設計
US6040431A (en) * 1995-06-07 2000-03-21 Stryker Corporation Single chain analogs of the TGF-β superfamily (morphons)
US5932716A (en) * 1995-07-26 1999-08-03 Creative Biomolecules, Inc. Morphogen-responsive regulatory elements
US6677432B1 (en) * 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
JP3786533B2 (ja) * 1998-11-12 2006-06-14 善彦 西村 ペプチド及び骨形成促進剤
DE60033576T2 (de) * 2000-11-06 2007-10-31 Thrasos, Inc., Waltham Methoden zum screening knochenmorphogenetishemimetika

Also Published As

Publication number Publication date
JP2000501744A (ja) 2000-02-15
DE69737809D1 (de) 2007-07-26
WO1997026277A2 (en) 1997-07-24
US6273598B1 (en) 2001-08-14
EP0876401A2 (en) 1998-11-11
AU2244997A (en) 1997-08-11
CA2244228A1 (en) 1997-07-24
WO1997026277A3 (en) 1997-09-25
US20020028453A1 (en) 2002-03-07
EP0876401B1 (en) 2007-06-13
AU725295B2 (en) 2000-10-12
DE69737809T2 (de) 2008-02-21

Similar Documents

Publication Publication Date Title
DE69737809D1 (de) Methoden zur herstellung von op-1 morphogen analoge
US5808918C1 (en) Hierarchical biological modelling system and method
ATE481480T1 (de) Methoden und zusammensetzungen zur herstellung von polypeptiden
ATE464067T1 (de) Bindegewebs wachstumsfaktor (ctgf)
ES2179273T3 (es) N-bencil-2-fenilindolas como agentes estrogenicos.
ATE234124T1 (de) Verfahren zur herstellung von wirkstoffhaltigen knochenzementen
ATE262844T1 (de) Vorrichtung zur benutzung mit einem chirurgischen navigationssystem
DK0493480T3 (da) Dehydrodidemnin B
DE69509628D1 (de) N-terminal chemisch modifizierte protein-zusammensetzungen und methoden
MX9803992A (es) Metodos para incrementar la masa de tejido muscular usando composiciones de la proteina ob.
SE9500566L (sv) L-platta
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
ES2053897T3 (es) Un metodo para estabilizar factores de coagulacion de la sangre.
DE69924846D1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
EP0956033A4 (en) TOTAL SYNTHESIS OF THE AMINO HIP ANALOG OF DIDEMNIN A
ES2160708T3 (es) Calibrador para ensayos de tiempo de protrombina (tp).
ATE258933T1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
DE69814109D1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
ATE287899T1 (de) Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen
BR9902056A (pt) Método para das às plantas resistência a compostos de controle de ervas daninhas e planta resistente a compostos de controle de ervas daninhas.
DE3667960D1 (de) Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung.
ATE353019T1 (de) Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung
ES2191728T3 (es) Nueva proteina analoga del receptor de ldl y gen que la codifica.
WO2004044838A3 (en) Computer system and methods for producing morphogen analogs of human tdf-1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties